Neuroprotective pathways

Neuroprotective pathways refer to the complex network of molecular signals and cellular processes that defend neurons from damage and promote their survival (PMID: 30214055). These pathways include the activation of antioxidant defenses via Nrf2, the inhibition of pro-apoptotic signals, and the modulation of neuroinflammation (StatPearls: Neuroprotection). In neurodegenerative conditions such as Alzheimer's and Parkinson's disease, these endogenous protective mechanisms are often overwhelmed or dysfunctional, leading to chronic neuronal loss (PubMed: 28855408). Pharmacological intervention aims to bolster these pathways using agents like NMDA receptor antagonists (e.g., Memantine) or free radical scavengers (e.g., Edaravone) (PubChem). These drugs work by reducing excitotoxicity, neutralizing reactive oxygen species, or providing neurotrophic support to vulnerable cell populations. Despite their potential, targeting these pathways is challenging due to the difficulty of crossing the blood-brain barrier and the risk of disrupting essential physiological signaling in non-target tissues. Current research focuses on identifying specific molecular nodes within these pathways, such as the TrkB receptor or the Sigma-1 receptor, to develop more precise therapeutic agents.

Other names

NeuroprotectionNeuronal survival pathwaysNeuroprotective signaling cascadesNervous system protective pathways

Drugs targeting these pathways typically act by reducing excitotoxicity, neutralizing reactive oxygen species, modulating neuroinflammation, or activating endogenous survival signaling cascades such as the PI3K/Akt or Nrf2/ARE pathways (PMID: 30214055).